← Back to Clinical Trials
Recruiting NCT07592728

NCT07592728 Brief Inhibitory Training for Eating - Intervention

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07592728
Status Recruiting
Phase —
Sponsor George Mason University
Condition Overweight and/or Obesity
Study Type INTERVENTIONAL
Enrollment 36 participants
Start Date 2026-05-01
Primary Completion 2027-02-10

Eligibility & Interventions

Sex All sexes
Min Age 14 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Daily inhibitory control training

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 36 participants in total. It began in 2026-05-01 with a primary completion date of 2027-02-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The purpose of this study is to conduct a proof-of-concept intervention of daily inhibitory control (IC) training. Aim 1 is to examine the feasibility, acceptability, and barriers of an IC training EMI in adolescents' daily life. Aim 2 is to evaluate the efficacy of IC training for modifying the hypothesized intervention mechanism: food-related IC and eating regulation. In the study, participants will: Complete questionnaires and cognitive tasks Receive a short nutrition education Complete three weeks of daily brain games on your phone

Eligibility Criteria

Inclusion Criteria: * 14-17 years old * Have overweight or obesity (BMI-z≥85th percentile) * Have a smartphone * Can read and speak English * Interest in improving one's diet. Exclusion Criteria: * Not currently in eating disorder or weight loss treatment or receiving pharmacological/surgical treatment for obesity in the past four weeks * Not meeting criteria for atypical anorexia nervosa or bulimia nervosa

Contact & Investigator

Central Contact

Tyler Mason, PhD

✉ tmason24@gmu.edu

📞 703-993-1000

Principal Investigator

Tyler Mason, PhD

PRINCIPAL INVESTIGATOR

George Mason University

Frequently Asked Questions

Who can join the NCT07592728 clinical trial?

This trial is open to participants of all sexes, aged 14 Years or older, up to 17 Years, studying Overweight and/or Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07592728 currently recruiting?

Yes, NCT07592728 is actively recruiting participants. Contact the research team at tmason24@gmu.edu for enrollment information.

Where is the NCT07592728 trial being conducted?

This trial is being conducted at Fairfax, United States.

Who is sponsoring the NCT07592728 clinical trial?

NCT07592728 is sponsored by George Mason University. The principal investigator is Tyler Mason, PhD at George Mason University. The trial plans to enroll 36 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology